GENZYME CORP
DelistedCIK 732485fmd_0DPNRGZS9568QWR68YWNZ0HFC3Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2007 to Dec 31, 2010, 12 periods
| Line item | FY2007 | FY2008 | FY2009 | FY2010 |
|---|---|---|---|---|
| Total revenues | 3,814 | 4,127 | 3,977 | 4,049 |
| Cost of revenue | 716 | 826 | 1,040 | 1,154 |
| Gross profit | 3,098 | 3,301 | 2,937 | 2,895 |
| Realized investment gains (losses) | 13 | 3 | 0 | 30 |
| Research and development | 738 | 1,294 | 834 | 847 |
| Selling, general and administrative | 1,187 | 1,173 | 1,244 | 1,554 |
| Operating income | 654 | 591 | 510 | 36 |
| Interest expense | 12 | 4 | 0 | 7 |
| Other non-operating income (expense) | 82 | 44 | 40 | (29) |
| Income before taxes | 736 | 635 | 550 | 7 |
| Income tax expense | 255 | 208 | 123 | (25) |
| Net income from continuing operations | 480 | 427 | 427 | 32 |
| Net income | 480 | 421 | 422 | 422 |
| Net income to common shareholders | – | 428 | 422 | 422 |